$SKYH
Sky Harbour Group Corp

2021 Q3 Form 10-Q Financial Statement

#000143774921025516 Filed on November 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2021 Q1
Revenue $0.00 $394.0K $390.0K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.050M $301.9K $224.8K
YoY Change 48062.39%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $270.0K $300.0K $297.0K
YoY Change
% of Gross Profit
Operating Expenses $1.050M $2.790M $1.727M
YoY Change 48062.39%
Operating Profit -$3.228M $1.586M $4.421M
YoY Change 148101.52%
Interest Expense -$2.167M $382.0K $459.0K
YoY Change
% of Operating Profit 24.09% 10.38%
Other Income/Expense, Net -$319.0K -$382.0K
YoY Change
Pretax Income -$3.217M $1.587M $4.430M
YoY Change 147582.14%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$3.217M -$2.778M -$2.046M
YoY Change 147582.14%
Net Earnings / Revenue -705.08% -524.62%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share -$189.2K $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 0.000 0.000 0.000
Diluted Shares Outstanding 0.000 0.000 0.000

Balance Sheet

Concept 2021 Q3 2021 Q2 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $139.6M $139.5M $139.6M
YoY Change 506092.06%
Cash & Equivalents $865.0K $20.58M $23.39M
Short-Term Investments $138.7M $138.7M $138.7M
Other Short-Term Assets $295.0K $322.2K $391.7K
YoY Change 43.28%
Inventory
Prepaid Expenses $295.0K $322.2K $391.7K
Receivables
Other Receivables
Total Short-Term Assets $139.9M $139.8M $140.0M
YoY Change 59814.78%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$5.00 $3.00 -$1.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $139.9M $139.8M $140.0M
Total Long-Term Assets -$5.00 $3.00 -$1.00
Total Assets $139.9M $139.8M $140.0M
YoY Change 59814.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $370.3K $212.9K $125.6K
YoY Change 510.23%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.000M $0.00 $0.00
YoY Change 566.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.130M $4.972M $4.885M
YoY Change 2809.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.65M $11.47M $13.36M
YoY Change
Total Long-Term Liabilities $13.65M $11.47M $13.36M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.130M $4.972M $4.885M
Total Long-Term Liabilities $13.65M $11.47M $13.36M
Total Liabilities $19.78M $16.44M $18.24M
YoY Change 9287.64%
SHAREHOLDERS EQUITY
Retained Earnings -$18.58M -$15.37M -$16.95M
YoY Change 853171.85%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$18.58M -$15.37M -$16.95M
YoY Change
Total Liabilities & Shareholders Equity $139.9M $139.8M $140.0M
YoY Change 59814.78%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2021 Q1
OPERATING ACTIVITIES
Net Income -$3.217M -$2.778M -$2.046M
YoY Change 147582.14%
Depreciation, Depletion And Amortization $270.0K $300.0K $297.0K
YoY Change
Cash From Operating Activities -$855.8K -$143.1K -$1.272M
YoY Change 39194.31%
INVESTING ACTIVITIES
Capital Expenditures $2.690M $1.670M $10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$15.16K $4.100K -$17.34K
YoY Change
Cash From Investing Activities -$15.16K $4.100K -$1.273M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.000M 30.00K $25.86M
YoY Change 3260.44%
NET CHANGE
Cash From Operating Activities -855.8K -143.1K -$1.272M
Cash From Investing Activities -15.16K 4.100K -$1.273M
Cash From Financing Activities 1.000M 30.00K $25.86M
Net Change In Cash 129.0K -139.0K $23.32M
YoY Change 367.77%
FREE CASH FLOW
Cash From Operating Activities -$855.8K -$143.1K -$1.272M
Capital Expenditures $2.690M $1.670M $10.00K
Free Cash Flow -$3.546M -$1.813M -$1.282M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2021Q3 ysac Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
4759615 USD
CY2020Q4 ysac Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
4759615 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6129902 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4913543 USD
CY2021Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
13648074 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
18003841 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
370287 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
153928 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1000000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q3 ysac Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1 pure
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Cash
Cash
865018 USD
CY2020Q4 us-gaap Cash
Cash
1122194 USD
CY2021Q3 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
138742756 USD
CY2020Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
138716226 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
295041 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
403186 USD
CY2021Q3 us-gaap Assets
Assets
139902815 USD
CY2020Q4 us-gaap Assets
Assets
140241606 USD
CY2021Q3 us-gaap Liabilities
Liabilities
19777976 USD
CY2020Q4 us-gaap Liabilities
Liabilities
22917384 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18584261 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21384878 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-18583921 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-21384538 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
139902815 USD
us-gaap Professional Fees
ProfessionalFees
1074639 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
-0 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140241606 USD
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
823735 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
-0 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-108145 USD
CY2020Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
216359 USD
us-gaap Net Income Loss
NetIncomeLoss
2800617 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2178 USD
CY2021Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
21803 USD
CY2020Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
-0 USD
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
150000 USD
CY2020Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
-0 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
204406 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2178 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
352029 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2178 USD
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2177885 USD
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4355766 USD
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3227829 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2178 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2779098 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2178 USD
CY2021Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
9500 USD
CY2020Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
0 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
23387 USD
CY2020Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
0 USD
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1812 USD
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1868 USD
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3216517 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2178 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2800617 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2178 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3216517 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2178 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2178 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
22822 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-21384538 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4430213 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-16954325 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1586921 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-15367404 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3216517 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-18583921 USD
us-gaap Net Income Loss
NetIncomeLoss
2800617 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2178 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1868 USD
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-0 USD
ysac Issuance Costs Warrants
IssuanceCostsWarrants
0 USD
CY2020Q3 ysac Issuance Costs Warrants
IssuanceCostsWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4355766 USD
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1228777 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
901737862 USD
CY2020Q3 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
901766261 USD
CY2020Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28399 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2021Q3 ysac Business Combination Required Fair Market Value Percentage Of Net Assets Held In Trust Account
BusinessCombinationRequiredFairMarketValuePercentageOfNetAssetsHeldInTrustAccount
0.80 pure
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2178 USD
CY2021Q3 ysac Business Combination Minimum Percentage Of Voting Interest Acquired
BusinessCombinationMinimumPercentageOfVotingInterestAcquired
0.50 pure
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
CY2020Q3 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000 USD
CY2020Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
-0 USD
CY2020Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
145242 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000000 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29758 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-257176 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27580 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1122194 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
865018 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27580 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020Q3 us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q4 ysac Equity Issued During Period Price Per Unit
EquityIssuedDuringPeriodPricePerUnit
10.20
CY2021Q3 ysac Business Combination Required Net Tangible Assets
BusinessCombinationRequiredNetTangibleAssets
5000001 USD
CY2021Q3 ysac Stock Redeemed Maximum Percentage Of Outstanding Shares
StockRedeemedMaximumPercentageOfOutstandingShares
0.15 pure
CY2021Q3 ysac Percentage Of Shares Mandatorily Redeemed If Fail To Complete Business Combination
PercentageOfSharesMandatorilyRedeemedIfFailToCompleteBusinessCombination
1 pure
ysac Business Combination Period From Ipo For Mandatory Combination
BusinessCombinationPeriodFromIpoForMandatoryCombination
P15M
ysac Maximum Dissolution Expenses Failure To Complete Business Combination
MaximumDissolutionExpensesFailureToCompleteBusinessCombination
100000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Concentration of Credit Risk</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, <em style="font: inherit;"> may </em>exceed the Federal Depository Insurance Coverage of <em style="font: inherit;">$250,000.</em> At <em style="font: inherit;"> September 30, 2021</em>, the Company has <em style="font: inherit;">not</em> experienced losses on these accounts and management believes the Company is <em style="font: inherit;">not</em> exposed to significant risks on such accounts.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"> </p>
CY2021Q3 ysac Underwriting Agreement Cash Underwriting Discount Per Unit
UnderwritingAgreementCashUnderwritingDiscountPerUnit
0.20
CY2021Q3 ysac Underwriting Agreement Cash Underwriting Discount Aggregate Amount
UnderwritingAgreementCashUnderwritingDiscountAggregateAmount
2500000 USD
CY2021Q3 ysac Underwriting Agreement Deferred Fee Per Unit
UnderwritingAgreementDeferredFeePerUnit
0.35
CY2021Q3 ysac Underwriting Agreement Cash Underwriting Discount Aggregate Amount Including Underwriter Shares
UnderwritingAgreementCashUnderwritingDiscountAggregateAmountIncludingUnderwriterShares
4759615 USD
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4355766 USD

Files In Submission

Name View Source Status
0001437749-21-025516-index-headers.html Edgar Link pending
0001437749-21-025516-index.html Edgar Link pending
0001437749-21-025516.txt Edgar Link pending
0001437749-21-025516-xbrl.zip Edgar Link pending
ex_281981.htm Edgar Link pending
ex_281982.htm Edgar Link pending
ex_281983.htm Edgar Link pending
ex_281984.htm Edgar Link pending
ex_281985.htm Edgar Link pending
ex_281986.htm Edgar Link pending
ex_299828.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ysac-20210930.xsd Edgar Link pending
ysac-20210930_cal.xml Edgar Link unprocessable
ysac-20210930_def.xml Edgar Link unprocessable
ysac-20210930_lab.xml Edgar Link unprocessable
ysac-20210930_pre.xml Edgar Link unprocessable
ysac20210930_10q.htm Edgar Link pending
ysac20210930_10q_htm.xml Edgar Link completed